Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation.

Volume: 72, Issue: 1, Pages: 315 - 329
Published: Jul 1, 2020
Abstract
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies targeting immune checkpoint molecules. ICIs are an immunotherapy for the treatment of many advanced malignancies. The advent of ICIs has been a major breakthrough in the field of oncology, a fact recognized by the 2018 Nobel Prize in Physiology or Medicine being awarded for the discovery. The Food and Drug Administration approved the first ICI, ipilimumab, in 2011 for the treatment of...
Paper Details
Title
Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation.
Published Date
Jul 1, 2020
Journal
Volume
72
Issue
1
Pages
315 - 329
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.